Back to trial details

Intake questionnaire

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Applying to Tennessee Oncology PLLC · Nashville, Tennessee

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced HR+/HER2- Breast Cancer?
3. Are you able to travel to Nashville for study visits?